• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® LYME IGG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® LYME IGG Back to Search Results
Catalog Number 30320
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
A customer in (b)(6) contacted biomérieux to report the occurrence a false negative patient result in association with the vidas® lyme igg assay (ref.30320).The initial result was 0.19 (negative); repeat result was 0.26 (positive).The customer also indicated that qc is inconsistent for the lyme igg assay.There is no indication or report from the laboratory or a physician that the discrepant result led to any adverse event related to the patient's state of health.Biomérieux requested strain submittal from the customer.A biomérieux internal investigation has been initiated.Note: reference 30320 (vidas lyme igg) is not registered in the united states.The u.S.Similar device is product reference 417401 (vidas lyme igg ii).
 
Manufacturer Narrative
An internal investigation was performed for a false negative result in association with vidas® lyme igg (1006179040).Complaint trending analysis: four complaints for the external quality control issue on vidas lyg batch 1006179040/181125-0 linked to the accurun quality control sample.One complaint for sensitivity issue on vidas lyg batch 1006179040/181125-0 linked to the patient clinical context.There is neither capa nor non conformity linked to this issue.Quality control records: the analysis of the batch history records of vidas lyg batch 1006179040/181125-0 showed no anomaly during the manufacturing, control and packaging processes.Study of internal samples control charts: this analysis was carried out on six internal positive controls that included three samples with high test values and three samples with test values close to the cut-off for vidas lyg batch 181125-0 compared to three other batches (180802-0, 180929-0 and 190104-0).All the results were within acceptable ranges and vidas lyg batch 1006179040/181125-0 conformed to the product specifications.Tests performed internally: biomérieux tested six internal samples from the activity panel on vidas lyg batch 1006179040/181125-0 compared to two other batches manufactured using different raw material.Although, vidas lyg batch 1006179040/181125-0 gives slightly lower test values, all the results are within the acceptable ranges.The customer's accurun sample gave positive results (between 3.19 and 4.21 tv) with the three vidas lyg batches (181125-0, 180929-0 and 190821-0).Testing reproduced the lower result observed by the customer with vidas lyg batch 1006179040/181125-0.The patient sample identified (b)(6) is positive with vidas lyg batches 180929-0 and 190821-0 but close to the cut-off (0.18 tv) with a negative interpretation when testing with vidas lyg batch 1006179040/181125-0.Testing reproduced a negative result observed by the customer when using vidas lyg batch 1006179040/181125-0.Tests performed by an external laboratory (biomnis): the patient sample (b)(6) gave a positive interpretation with presence of bands anti vlse, anti p41 et anti p18.The analysis performed showed that vidas lyg batch 1006179040/181125-0 was in the trend of the parameter regarding all the required criteria.Although vidas lyg batch 1006179040/181125-0 had a trend to give lower results, all the results were within acceptable ranges and we did not observed any degradation of its activity compared to its release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® LYME IGG
Type of Device
VIDAS® LYME IGG
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280,
FR 
MDR Report Key7961108
MDR Text Key123569460
Report Number3002769706-2018-00211
Device Sequence Number1
Product Code LSR
Combination Product (y/n)N
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 03/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/25/2018
Device Catalogue Number30320
Device Lot Number1006179040
Was Device Available for Evaluation? No
Date Manufacturer Received02/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-